CellJClub
Cancer competition for vitamin B2 creates metabolic checkpoint for T cell ferroptosis.
Cell · · Journal Article
Chen, Li + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Tumors use SLC52A2 to outcompete T cells for vitamin B2, creating a metabolic checkpoint that triggers T cell ferroptosis and impairs antitumor immunity.
- Why it matters: Understanding how tumors evade immune responses through metabolic competition is crucial for developing effective immunotherapies, as the mechanisms remain largely unknown.
- What they did: The study used the CareSLCs platform to identify that SLC52A3-mediated vitamin B2 uptake is essential for T cell function, while tumors preferentially employ SLC52A2 to scavenge VB2, with tumor SLC52A2 ablation enhancing T cell activity.
- The result: High tumoral SLC52A2 correlates with T cell dysfunction and poor survival, while dietary VB2 intake and SLC52A3 overexpression improve CAR-T cell efficacy, suggesting potential therapeutic strategies.
The findingWhy it mattersWhat they didThe result
- 1 opens in JClub